APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lisinopril

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lisinopril Market Analysis and Forecast 2026-2032

19 December 2025219 pages

Choose your research edition.

Industry ResearchLisinopril Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Lisinopril Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Lisinopril Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lisinopril Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Lisinopril Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Lisinopril market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lisinopril is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lisinopril is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lisinopril is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lisinopril is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Lisinopril include Teva Pharmaceuticals, Novartis, Mylan Pharmaceuticals, Astrazeneca, Wockhardt, West Ward Pharmaceutical, Watson Laboratories, Vintage Pharmaceuticals and SUN Pharm, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lisinopril, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lisinopril, also provides the sales of main regions and countries. Of the upcoming market potential for Lisinopril, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lisinopril sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lisinopril market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lisinopril sales, projected growth trends, production technology, application and end-user industry.

Lisinopril Segment by Company

Teva Pharmaceuticals

Novartis

Mylan Pharmaceuticals

Astrazeneca

Wockhardt

West Ward Pharmaceutical

Watson Laboratories

Vintage Pharmaceuticals

SUN Pharm

Ranbaxy Pharmaceuticals

Prinston

Merck Research Laboratories

Lupin

Lek Pharmaceuticals

Ivax Pharmaceuticals

Invagen Pharms

Hikma

CASI Pharms

Aurobindo Pharma

Apotex

Alvogen

Actavis Elizabeth

Accord Hlthcare

Lisinopril Segment by Type

10mg

2.5mg

20mg

30mg

40mg

5mg

Lisinopril Segment by Application

Hospital

Drug Store

Lisinopril Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lisinopril market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lisinopril and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lisinopril.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Lisinopril in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Lisinopril manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lisinopril sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lisinopril Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10mg Major Manufacturers Table 3. 2.5mg Major Manufacturers Table 4. 20mg Major Manufacturers Table 5. 30mg Major Manufacturers Table 6. 40mg Major Manufacturers Table 7. 5mg Major Manufacturers Table 8. Global Lisinopril Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hospital Major Manufacturers Table 10. Drug Store Major Manufacturers Table 11. Lisinopril Industry Trends Table 12. Lisinopril Industry Drivers Table 13. Lisinopril Industry Opportunities and Challenges Table 14. Lisinopril Industry Restraints Table 15. Global Lisinopril Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Lisinopril Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Lisinopril Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Lisinopril Revenue Market Share by Region (2021-2026) Table 19. Global Lisinopril Revenue Market Share by Region (2027-2032) Table 20. Global Lisinopril Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Lisinopril Sales by Region (2021-2026) & (K Units) Table 22. Global Lisinopril Sales by Region (2027-2032) & (K Units) Table 23. Global Lisinopril Sales Market Share by Region (2021-2026) Table 24. Global Lisinopril Sales Market Share by Region (2027-2032) Table 25. Global Lisinopril Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Lisinopril Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Lisinopril Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Lisinopril Sales Market Share by Manufacturers (2021-2026) Table 29. Global Lisinopril Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Lisinopril Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Lisinopril Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Lisinopril Manufacturers, Product Type & Application Table 33. Global Lisinopril Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Lisinopril by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Lisinopril Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Lisinopril Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Lisinopril Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Lisinopril Revenue Market Share by Type (2021-2026) Table 40. Global Lisinopril Revenue Market Share by Type (2027-2032) Table 41. Global Lisinopril Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Lisinopril Sales by Type (2021-2026) & (K Units) Table 43. Global Lisinopril Sales by Type (2027-2032) & (K Units) Table 44. Global Lisinopril Sales Market Share by Type (2021-2026) Table 45. Global Lisinopril Sales Market Share by Type (2027-2032) Table 46. Global Lisinopril Price by Type (2021-2026) & (US$/Unit) Table 47. Global Lisinopril Price by Type (2027-2032) & (US$/Unit) Table 48. Global Lisinopril Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Lisinopril Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Lisinopril Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Lisinopril Revenue Market Share by Application (2021-2026) Table 52. Global Lisinopril Revenue Market Share by Application (2027-2032) Table 53. Global Lisinopril Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Lisinopril Sales by Application (2021-2026) & (K Units) Table 55. Global Lisinopril Sales by Application (2027-2032) & (K Units) Table 56. Global Lisinopril Sales Market Share by Application (2021-2026) Table 57. Global Lisinopril Sales Market Share by Application (2027-2032) Table 58. Global Lisinopril Price by Application (2021-2026) & (US$/Unit) Table 59. Global Lisinopril Price by Application (2027-2032) & (US$/Unit) Table 60. Teva Pharmaceuticals Company Information Table 61. Teva Pharmaceuticals Business Overview Table 62. Teva Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Teva Pharmaceuticals Lisinopril Product Portfolio Table 64. Teva Pharmaceuticals Recent Development Table 65. Novartis Company Information Table 66. Novartis Business Overview Table 67. Novartis Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Novartis Lisinopril Product Portfolio Table 69. Novartis Recent Development Table 70. Mylan Pharmaceuticals Company Information Table 71. Mylan Pharmaceuticals Business Overview Table 72. Mylan Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Mylan Pharmaceuticals Lisinopril Product Portfolio Table 74. Mylan Pharmaceuticals Recent Development Table 75. Astrazeneca Company Information Table 76. Astrazeneca Business Overview Table 77. Astrazeneca Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Astrazeneca Lisinopril Product Portfolio Table 79. Astrazeneca Recent Development Table 80. Wockhardt Company Information Table 81. Wockhardt Business Overview Table 82. Wockhardt Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Wockhardt Lisinopril Product Portfolio Table 84. Wockhardt Recent Development Table 85. West Ward Pharmaceutical Company Information Table 86. West Ward Pharmaceutical Business Overview Table 87. West Ward Pharmaceutical Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. West Ward Pharmaceutical Lisinopril Product Portfolio Table 89. West Ward Pharmaceutical Recent Development Table 90. Watson Laboratories Company Information Table 91. Watson Laboratories Business Overview Table 92. Watson Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Watson Laboratories Lisinopril Product Portfolio Table 94. Watson Laboratories Recent Development Table 95. Vintage Pharmaceuticals Company Information Table 96. Vintage Pharmaceuticals Business Overview Table 97. Vintage Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Vintage Pharmaceuticals Lisinopril Product Portfolio Table 99. Vintage Pharmaceuticals Recent Development Table 100. SUN Pharm Company Information Table 101. SUN Pharm Business Overview Table 102. SUN Pharm Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. SUN Pharm Lisinopril Product Portfolio Table 104. SUN Pharm Recent Development Table 105. Ranbaxy Pharmaceuticals Company Information Table 106. Ranbaxy Pharmaceuticals Business Overview Table 107. Ranbaxy Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Ranbaxy Pharmaceuticals Lisinopril Product Portfolio Table 109. Ranbaxy Pharmaceuticals Recent Development Table 110. Prinston Company Information Table 111. Prinston Business Overview Table 112. Prinston Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Prinston Lisinopril Product Portfolio Table 114. Prinston Recent Development Table 115. Merck Research Laboratories Company Information Table 116. Merck Research Laboratories Business Overview Table 117. Merck Research Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Merck Research Laboratories Lisinopril Product Portfolio Table 119. Merck Research Laboratories Recent Development Table 120. Lupin Company Information Table 121. Lupin Business Overview Table 122. Lupin Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Lupin Lisinopril Product Portfolio Table 124. Lupin Recent Development Table 125. Lek Pharmaceuticals Company Information Table 126. Lek Pharmaceuticals Business Overview Table 127. Lek Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Lek Pharmaceuticals Lisinopril Product Portfolio Table 129. Lek Pharmaceuticals Recent Development Table 130. Ivax Pharmaceuticals Company Information Table 131. Ivax Pharmaceuticals Business Overview Table 132. Ivax Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Ivax Pharmaceuticals Lisinopril Product Portfolio Table 134. Ivax Pharmaceuticals Recent Development Table 135. Invagen Pharms Company Information Table 136. Invagen Pharms Business Overview Table 137. Invagen Pharms Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Invagen Pharms Lisinopril Product Portfolio Table 139. Invagen Pharms Recent Development Table 140. Hikma Company Information Table 141. Hikma Business Overview Table 142. Hikma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Hikma Lisinopril Product Portfolio Table 144. Hikma Recent Development Table 145. CASI Pharms Company Information Table 146. CASI Pharms Business Overview Table 147. CASI Pharms Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. CASI Pharms Lisinopril Product Portfolio Table 149. CASI Pharms Recent Development Table 150. Aurobindo Pharma Company Information Table 151. Aurobindo Pharma Business Overview Table 152. Aurobindo Pharma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Aurobindo Pharma Lisinopril Product Portfolio Table 154. Aurobindo Pharma Recent Development Table 155. Apotex Company Information Table 156. Apotex Business Overview Table 157. Apotex Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Apotex Lisinopril Product Portfolio Table 159. Apotex Recent Development Table 160. Alvogen Company Information Table 161. Alvogen Business Overview Table 162. Alvogen Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Alvogen Lisinopril Product Portfolio Table 164. Alvogen Recent Development Table 165. Actavis Elizabeth Company Information Table 166. Actavis Elizabeth Business Overview Table 167. Actavis Elizabeth Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Actavis Elizabeth Lisinopril Product Portfolio Table 169. Actavis Elizabeth Recent Development Table 170. Accord Hlthcare Company Information Table 171. Accord Hlthcare Business Overview Table 172. Accord Hlthcare Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 173. Accord Hlthcare Lisinopril Product Portfolio Table 174. Accord Hlthcare Recent Development Table 175. North America Lisinopril Revenue by Type (2021-2026) & (US$ Million) Table 176. North America Lisinopril Revenue by Type (2027-2032) & (US$ Million) Table 177. North America Lisinopril Sales by Type (2021-2026) & (K Units) Table 178. North America Lisinopril Sales by Type (2027-2032) & (K Units) Table 179. North America Lisinopril Sales Price by Type (2021-2026) & (US$/Unit) Table 180. North America Lisinopril Sales Price by Type (2027-2032) & (US$/Unit) Table 181. North America Lisinopril Revenue by Application (2021-2026) & (US$ Million) Table 182. North America Lisinopril Revenue by Application (2027-2032) & (US$ Million) Table 183. North America Lisinopril Sales by Application (2021-2026) & (K Units) Table 184. North America Lisinopril Sales by Application (2027-2032) & (K Units) Table 185. North America Lisinopril Sales Price by Application (2021-2026) & (US$/Unit) Table 186. North America Lisinopril Sales Price by Application (2027-2032) & (US$/Unit) Table 187. North America Lisinopril Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. North America Lisinopril Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. North America Lisinopril Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. North America Lisinopril Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 191. North America Lisinopril Sales by Country (2021-2026) & (K Units) Table 192. North America Lisinopril Sales by Country (2027-2032) & (K Units) Table 193. North America Lisinopril Sales Price by Country (2021-2026) & (US$/Unit) Table 194. North America Lisinopril Sales Price by Country (2027-2032) & (US$/Unit) Table 195. United States Lisinopril Revenue (2021-2032) & (US$ Million) Table 196. Canada Lisinopril Revenue (2021-2032) & (US$ Million) Table 197. Europe Lisinopril Revenue by Type (2021-2026) & (US$ Million) Table 198. Europe Lisinopril Revenue by Type (2027-2032) & (US$ Million) Table 199. Europe Lisinopril Sales by Type (2021-2026) & (K Units) Table 200. Europe Lisinopril Sales by Type (2027-2032) & (K Units) Table 201. Europe Lisinopril Sales Price by Type (2021-2026) & (US$/Unit) Table 202. Europe Lisinopril Sales Price by Type (2027-2032) & (US$/Unit) Table 203. Europe Lisinopril Revenue by Application (2021-2026) & (US$ Million) Table 204. Europe Lisinopril Revenue by Application (2027-2032) & (US$ Million) Table 205. Europe Lisinopril Sales by Application (2021-2026) & (K Units) Table 206. Europe Lisinopril Sales by Application (2027-2032) & (K Units) Table 207. Europe Lisinopril Sales Price by Application (2021-2026) & (US$/Unit) Table 208. Europe Lisinopril Sales Price by Application (2027-2032) & (US$/Unit) Table 209. Europe Lisinopril Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. Europe Lisinopril Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. Europe Lisinopril Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. Europe Lisinopril Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 213. Europe Lisinopril Sales by Country (2021-2026) & (K Units) Table 214. Europe Lisinopril Sales by Country (2027-2032) & (K Units) Table 215. Europe Lisinopril Sales Price by Country (2021-2026) & (US$/Unit) Table 216. Europe Lisinopril Sales Price by Country (2027-2032) & (US$/Unit) Table 217. Germany Lisinopril Revenue (2021-2032) & (US$ Million) Table 218. France Lisinopril Revenue (2021-2032) & (US$ Million) Table 219. U.K. Lisinopril Revenue (2021-2032) & (US$ Million) Table 220. Italy Lisinopril Revenue (2021-2032) & (US$ Million) Table 221. Netherlands Lisinopril Revenue (2021-2032) & (US$ Million) Table 222. China Lisinopril Revenue by Type (2021-2026) & (US$ Million) Table 223. China Lisinopril Revenue by Type (2027-2032) & (US$ Million) Table 224. China Lisinopril Sales by Type (2021-2026) & (K Units) Table 225. China Lisinopril Sales by Type (2027-2032) & (K Units) Table 226. China Lisinopril Sales Price by Type (2021-2026) & (US$/Unit) Table 227. China Lisinopril Sales Price by Type (2027-2032) & (US$/Unit) Table 228. China Lisinopril Revenue by Application (2021-2026) & (US$ Million) Table 229. China Lisinopril Revenue by Application (2027-2032) & (US$ Million) Table 230. China Lisinopril Sales by Application (2021-2026) & (K Units) Table 231. China Lisinopril Sales by Application (2027-2032) & (K Units) Table 232. China Lisinopril Sales Price by Application (2021-2026) & (US$/Unit) Table 233. China Lisinopril Sales Price by Application (2027-2032) & (US$/Unit) Table 234. Asia Lisinopril Revenue by Type (2021-2026) & (US$ Million) Table 235. Asia Lisinopril Revenue by Type (2027-2032) & (US$ Million) Table 236. Asia Lisinopril Sales by Type (2021-2026) & (K Units) Table 237. Asia Lisinopril Sales by Type (2027-2032) & (K Units) Table 238. Asia Lisinopril Sales Price by Type (2021-2026) & (US$/Unit) Table 239. Asia Lisinopril Sales Price by Type (2027-2032) & (US$/Unit) Table 240. Asia Lisinopril Revenue by Application (2021-2026) & (US$ Million) Table 241. Asia Lisinopril Revenue by Application (2027-2032) & (US$ Million) Table 242. Asia Lisinopril Sales by Application (2021-2026) & (K Units) Table 243. Asia Lisinopril Sales by Application (2027-2032) & (K Units) Table 244. Asia Lisinopril Sales Price by Application (2021-2026) & (US$/Unit) Table 245. Asia Lisinopril Sales Price by Application (2027-2032) & (US$/Unit) Table 246. Asia Lisinopril Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 247. Asia Lisinopril Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 248. Asia Lisinopril Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 249. Asia Lisinopril Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 250. Asia Lisinopril Sales by Country (2021-2026) & (K Units) Table 251. Asia Lisinopril Sales by Country (2027-2032) & (K Units) Table 252. Asia Lisinopril Sales Price by Country (2021-2026) & (US$/Unit) Table 253. Asia Lisinopril Sales Price by Country (2027-2032) & (US$/Unit) Table 254. Japan Lisinopril Revenue (2021-2032) & (US$ Million) Table 255. South Korea Lisinopril Revenue (2021-2032) & (US$ Million) Table 256. India Lisinopril Revenue (2021-2032) & (US$ Million) Table 257. Australia Lisinopril Revenue (2021-2032) & (US$ Million) Table 258. China Taiwan Lisinopril Revenue (2021-2032) & (US$ Million) Table 259. Southeast Asia Lisinopril Revenue (2021-2032) & (US$ Million) Table 260. SAMEA Lisinopril Revenue by Type (2021-2026) & (US$ Million) Table 261. SAMEA Lisinopril Revenue by Type (2027-2032) & (US$ Million) Table 262. SAMEA Lisinopril Sales by Type (2021-2026) & (K Units) Table 263. SAMEA Lisinopril Sales by Type (2027-2032) & (K Units) Table 264. SAMEA Lisinopril Sales Price by Type (2021-2026) & (US$/Unit) Table 265. SAMEA Lisinopril Sales Price by Type (2027-2032) & (US$/Unit) Table 266. SAMEA Lisinopril Revenue by Application (2021-2026) & (US$ Million) Table 267. SAMEA Lisinopril Revenue by Application (2027-2032) & (US$ Million) Table 268. SAMEA Lisinopril Sales by Application (2021-2026) & (K Units) Table 269. SAMEA Lisinopril Sales by Application (2027-2032) & (K Units) Table 270. SAMEA Lisinopril Sales Price by Application (2021-2026) & (US$/Unit) Table 271. SAMEA Lisinopril Sales Price by Application (2027-2032) & (US$/Unit) Table 272. SAMEA Lisinopril Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 273. SAMEA Lisinopril Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 274. SAMEA Lisinopril Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 275. SAMEA Lisinopril Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 276. SAMEA Lisinopril Sales by Country (2021-2026) & (K Units) Table 277. SAMEA Lisinopril Sales by Country (2027-2032) & (K Units) Table 278. SAMEA Lisinopril Sales Price by Country (2021-2026) & (US$/Unit) Table 279. SAMEA Lisinopril Sales Price by Country (2027-2032) & (US$/Unit) Table 280. Brazil Lisinopril Revenue (2021-2032) & (US$ Million) Table 281. Argentina Lisinopril Revenue (2021-2032) & (US$ Million) Table 282. Chile Lisinopril Revenue (2021-2032) & (US$ Million) Table 283. Colombia Lisinopril Revenue (2021-2032) & (US$ Million) Table 284. Peru Lisinopril Revenue (2021-2032) & (US$ Million) Table 285. Saudi Arabia Lisinopril Revenue (2021-2032) & (US$ Million) Table 286. Israel Lisinopril Revenue (2021-2032) & (US$ Million) Table 287. UAE Lisinopril Revenue (2021-2032) & (US$ Million) Table 288. Turkey Lisinopril Revenue (2021-2032) & (US$ Million) Table 289. Iran Lisinopril Revenue (2021-2032) & (US$ Million) Table 290. Egypt Lisinopril Revenue (2021-2032) & (US$ Million) Table 291. Key Raw Materials Table 292. Raw Materials Key Suppliers Table 293. Lisinopril Distributors List Table 294. Lisinopril Customers List Table 295. Research Programs/Design for This Report Table 296. Authors List of This Report Table 297. Secondary Sources Table 298. Primary Sources List of Figures Figure 1. Lisinopril Image Figure 2. Global Lisinopril Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lisinopril Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10mg Image Figure 5. 2.5mg Image Figure 6. 20mg Image Figure 7. 30mg Image Figure 8. 40mg Image Figure 9. 5mg Image Figure 10. Global Lisinopril Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Lisinopril Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hospital Image Figure 13. Drug Store Image Figure 14. Global Lisinopril Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Lisinopril Revenue (2021-2032) & (US$ Million) Figure 16. Global Lisinopril Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Lisinopril Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Lisinopril Revenue Market Share by Region (2021-2032) Figure 19. Global Lisinopril Sales (2021-2032) & (K Units) Figure 20. Global Lisinopril Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Lisinopril Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Lisinopril Sales YoY (2021-2032) & (K Units) Figure 23. Europe Lisinopril Sales YoY (2021-2032) & (K Units) Figure 24. China Lisinopril Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Lisinopril Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Lisinopril Sales YoY (2021-2032) & (K Units) Figure 27. Global Lisinopril Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Lisinopril Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Lisinopril Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Lisinopril Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Lisinopril Revenue Market Share by Type (2021-2032) Figure 33. Global Lisinopril Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Lisinopril Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Lisinopril Sales Market Share by Type (2021-2032) Figure 36. Global Lisinopril Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Lisinopril Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Lisinopril Revenue Market Share by Application (2021-2032) Figure 39. Global Lisinopril Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Lisinopril Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Lisinopril Sales Market Share by Application (2021-2032) Figure 42. North America Lisinopril Revenue Share by Type (2021-2032) Figure 43. North America Lisinopril Sales Share by Type (2021-2032) Figure 44. North America Lisinopril Revenue Share by Application (2021-2032) Figure 45. North America Lisinopril Sales Share by Application (2021-2032) Figure 46. North America Lisinopril Revenue Share by Country (2021-2032) Figure 47. North America Lisinopril Sales Share by Country (2021-2032) Figure 48. Europe Lisinopril Revenue Share by Type (2021-2032) Figure 49. Europe Lisinopril Sales Share by Type (2021-2032) Figure 50. Europe Lisinopril Revenue Share by Application (2021-2032) Figure 51. Europe Lisinopril Sales Share by Application (2021-2032) Figure 52. Europe Lisinopril Revenue Share by Country (2021-2032) Figure 53. Europe Lisinopril Sales Share by Country (2021-2032) Figure 54. China Lisinopril Revenue Share by Type (2021-2032) Figure 55. China Lisinopril Sales Share by Type (2021-2032) Figure 56. China Lisinopril Revenue Share by Application (2021-2032) Figure 57. China Lisinopril Sales Share by Application (2021-2032) Figure 58. Asia Lisinopril Revenue Share by Type (2021-2032) Figure 59. Asia Lisinopril Sales Share by Type (2021-2032) Figure 60. Asia Lisinopril Revenue Share by Application (2021-2032) Figure 61. Asia Lisinopril Sales Share by Application (2021-2032) Figure 62. Asia Lisinopril Revenue Share by Country (2021-2032) Figure 63. Asia Lisinopril Sales Share by Country (2021-2032) Figure 64. SAMEA Lisinopril Revenue Share by Type (2021-2032) Figure 65. SAMEA Lisinopril Sales Share by Type (2021-2032) Figure 66. SAMEA Lisinopril Revenue Share by Application (2021-2032) Figure 67. SAMEA Lisinopril Sales Share by Application (2021-2032) Figure 68. SAMEA Lisinopril Revenue Share by Country (2021-2032) Figure 69. SAMEA Lisinopril Sales Share by Country (2021-2032) Figure 70. Lisinopril Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Lisinopril Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 2.5mg
  • 20mg
  • 30mg
  • 40mg
  • 5mg
Applications
  • Hospital
  • Drug Store
Companies covered
  • Teva Pharmaceuticals
  • Novartis
  • Mylan Pharmaceuticals
  • Astrazeneca
  • Wockhardt
  • West Ward Pharmaceutical
  • Watson Laboratories
  • Vintage Pharmaceuticals
  • SUN Pharm
  • Ranbaxy Pharmaceuticals
  • Prinston
  • Merck Research Laboratories
  • Lupin
  • Lek Pharmaceuticals
  • Ivax Pharmaceuticals
  • Invagen Pharms
  • Hikma
  • CASI Pharms
  • Aurobindo Pharma
  • Apotex
  • Alvogen
  • Actavis Elizabeth
  • Accord Hlthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lisinopril Market by Type
  3. 1.2.1 Global Lisinopril Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10mg
  5. 1.2.3 2.5mg
  6. 1.2.4 20mg
  7. 1.2.5 30mg
  8. 1.2.6 40mg
  9. 1.2.7 5mg
  10. 1.3 Lisinopril Market by Application
  11. 1.3.1 Global Lisinopril Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital
  13. 1.3.3 Drug Store
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Lisinopril Market Dynamics
  1. 2.1 Lisinopril Industry Trends
  2. 2.2 Lisinopril Industry Drivers
  3. 2.3 Lisinopril Industry Opportunities and Challenges
  4. 2.4 Lisinopril Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Lisinopril Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Lisinopril Revenue by Region
  3. 3.2.1 Global Lisinopril Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lisinopril Revenue by Region (2021-2026)
  5. 3.2.3 Global Lisinopril Revenue by Region (2027-2032)
  6. 3.2.4 Global Lisinopril Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Lisinopril Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Lisinopril Sales by Region
  9. 3.4.1 Global Lisinopril Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Lisinopril Sales by Region (2021-2026)
  11. 3.4.3 Global Lisinopril Sales by Region (2027-2032)
  12. 3.4.4 Global Lisinopril Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Lisinopril Revenue by Manufacturers
  2. 4.1.1 Global Lisinopril Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Lisinopril Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Lisinopril Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lisinopril Sales by Manufacturers
  6. 4.2.1 Global Lisinopril Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Lisinopril Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Lisinopril Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Lisinopril Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Lisinopril Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Lisinopril Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Lisinopril Manufacturers, Product Type & Application
  13. 4.7 Global Lisinopril Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Lisinopril Market CR5 and HHI
  16. 4.8.2 2025 Lisinopril Tier 1, Tier 2, and Tier 3
5 Lisinopril Market by Type
  1. 5.1 Global Lisinopril Revenue by Type
  2. 5.1.1 Global Lisinopril Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Lisinopril Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Lisinopril Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Lisinopril Sales by Type
  6. 5.2.1 Global Lisinopril Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lisinopril Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Lisinopril Sales Market Share by Type (2021-2032)
  9. 5.3 Global Lisinopril Price by Type
6 Lisinopril Market by Application
  1. 6.1 Global Lisinopril Revenue by Application
  2. 6.1.1 Global Lisinopril Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Lisinopril Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Lisinopril Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Lisinopril Sales by Application
  6. 6.2.1 Global Lisinopril Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Lisinopril Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Lisinopril Sales Market Share by Application (2021-2032)
  9. 6.3 Global Lisinopril Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceuticals
  2. 7.1.1 Teva Pharmaceuticals Company Information
  3. 7.1.2 Teva Pharmaceuticals Business Overview
  4. 7.1.3 Teva Pharmaceuticals Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceuticals Lisinopril Product Portfolio
  6. 7.1.5 Teva Pharmaceuticals Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Lisinopril Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Mylan Pharmaceuticals
  14. 7.3.1 Mylan Pharmaceuticals Company Information
  15. 7.3.2 Mylan Pharmaceuticals Business Overview
  16. 7.3.3 Mylan Pharmaceuticals Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Pharmaceuticals Lisinopril Product Portfolio
  18. 7.3.5 Mylan Pharmaceuticals Recent Developments
  19. 7.4 Astrazeneca
  20. 7.4.1 Astrazeneca Company Information
  21. 7.4.2 Astrazeneca Business Overview
  22. 7.4.3 Astrazeneca Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Astrazeneca Lisinopril Product Portfolio
  24. 7.4.5 Astrazeneca Recent Developments
  25. 7.5 Wockhardt
  26. 7.5.1 Wockhardt Company Information
  27. 7.5.2 Wockhardt Business Overview
  28. 7.5.3 Wockhardt Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Wockhardt Lisinopril Product Portfolio
  30. 7.5.5 Wockhardt Recent Developments
  31. 7.6 West Ward Pharmaceutical
  32. 7.6.1 West Ward Pharmaceutical Company Information
  33. 7.6.2 West Ward Pharmaceutical Business Overview
  34. 7.6.3 West Ward Pharmaceutical Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 West Ward Pharmaceutical Lisinopril Product Portfolio
  36. 7.6.5 West Ward Pharmaceutical Recent Developments
  37. 7.7 Watson Laboratories
  38. 7.7.1 Watson Laboratories Company Information
  39. 7.7.2 Watson Laboratories Business Overview
  40. 7.7.3 Watson Laboratories Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Watson Laboratories Lisinopril Product Portfolio
  42. 7.7.5 Watson Laboratories Recent Developments
  43. 7.8 Vintage Pharmaceuticals
  44. 7.8.1 Vintage Pharmaceuticals Company Information
  45. 7.8.2 Vintage Pharmaceuticals Business Overview
  46. 7.8.3 Vintage Pharmaceuticals Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Vintage Pharmaceuticals Lisinopril Product Portfolio
  48. 7.8.5 Vintage Pharmaceuticals Recent Developments
  49. 7.9 SUN Pharm
  50. 7.9.1 SUN Pharm Company Information
  51. 7.9.2 SUN Pharm Business Overview
  52. 7.9.3 SUN Pharm Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 SUN Pharm Lisinopril Product Portfolio
  54. 7.9.5 SUN Pharm Recent Developments
  55. 7.10 Ranbaxy Pharmaceuticals
  56. 7.10.1 Ranbaxy Pharmaceuticals Company Information
  57. 7.10.2 Ranbaxy Pharmaceuticals Business Overview
  58. 7.10.3 Ranbaxy Pharmaceuticals Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Ranbaxy Pharmaceuticals Lisinopril Product Portfolio
  60. 7.10.5 Ranbaxy Pharmaceuticals Recent Developments
  61. 7.11 Prinston
  62. 7.11.1 Prinston Company Information
  63. 7.11.2 Prinston Business Overview
  64. 7.11.3 Prinston Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Prinston Lisinopril Product Portfolio
  66. 7.11.5 Prinston Recent Developments
  67. 7.12 Merck Research Laboratories
  68. 7.12.1 Merck Research Laboratories Company Information
  69. 7.12.2 Merck Research Laboratories Business Overview
  70. 7.12.3 Merck Research Laboratories Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Merck Research Laboratories Lisinopril Product Portfolio
  72. 7.12.5 Merck Research Laboratories Recent Developments
  73. 7.13 Lupin
  74. 7.13.1 Lupin Company Information
  75. 7.13.2 Lupin Business Overview
  76. 7.13.3 Lupin Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Lupin Lisinopril Product Portfolio
  78. 7.13.5 Lupin Recent Developments
  79. 7.14 Lek Pharmaceuticals
  80. 7.14.1 Lek Pharmaceuticals Company Information
  81. 7.14.2 Lek Pharmaceuticals Business Overview
  82. 7.14.3 Lek Pharmaceuticals Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Lek Pharmaceuticals Lisinopril Product Portfolio
  84. 7.14.5 Lek Pharmaceuticals Recent Developments
  85. 7.15 Ivax Pharmaceuticals
  86. 7.15.1 Ivax Pharmaceuticals Company Information
  87. 7.15.2 Ivax Pharmaceuticals Business Overview
  88. 7.15.3 Ivax Pharmaceuticals Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Ivax Pharmaceuticals Lisinopril Product Portfolio
  90. 7.15.5 Ivax Pharmaceuticals Recent Developments
  91. 7.16 Invagen Pharms
  92. 7.16.1 Invagen Pharms Company Information
  93. 7.16.2 Invagen Pharms Business Overview
  94. 7.16.3 Invagen Pharms Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Invagen Pharms Lisinopril Product Portfolio
  96. 7.16.5 Invagen Pharms Recent Developments
  97. 7.17 Hikma
  98. 7.17.1 Hikma Company Information
  99. 7.17.2 Hikma Business Overview
  100. 7.17.3 Hikma Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Hikma Lisinopril Product Portfolio
  102. 7.17.5 Hikma Recent Developments
  103. 7.18 CASI Pharms
  104. 7.18.1 CASI Pharms Company Information
  105. 7.18.2 CASI Pharms Business Overview
  106. 7.18.3 CASI Pharms Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 CASI Pharms Lisinopril Product Portfolio
  108. 7.18.5 CASI Pharms Recent Developments
  109. 7.19 Aurobindo Pharma
  110. 7.19.1 Aurobindo Pharma Company Information
  111. 7.19.2 Aurobindo Pharma Business Overview
  112. 7.19.3 Aurobindo Pharma Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Aurobindo Pharma Lisinopril Product Portfolio
  114. 7.19.5 Aurobindo Pharma Recent Developments
  115. 7.20 Apotex
  116. 7.20.1 Apotex Company Information
  117. 7.20.2 Apotex Business Overview
  118. 7.20.3 Apotex Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Apotex Lisinopril Product Portfolio
  120. 7.20.5 Apotex Recent Developments
  121. 7.21 Alvogen
  122. 7.21.1 Alvogen Company Information
  123. 7.21.2 Alvogen Business Overview
  124. 7.21.3 Alvogen Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Alvogen Lisinopril Product Portfolio
  126. 7.21.5 Alvogen Recent Developments
  127. 7.22 Actavis Elizabeth
  128. 7.22.1 Actavis Elizabeth Company Information
  129. 7.22.2 Actavis Elizabeth Business Overview
  130. 7.22.3 Actavis Elizabeth Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Actavis Elizabeth Lisinopril Product Portfolio
  132. 7.22.5 Actavis Elizabeth Recent Developments
  133. 7.23 Accord Hlthcare
  134. 7.23.1 Accord Hlthcare Company Information
  135. 7.23.2 Accord Hlthcare Business Overview
  136. 7.23.3 Accord Hlthcare Lisinopril Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Accord Hlthcare Lisinopril Product Portfolio
  138. 7.23.5 Accord Hlthcare Recent Developments
8 North America
  1. 8.1 North America Lisinopril Market Size by Type
  2. 8.1.1 North America Lisinopril Revenue by Type (2021-2032)
  3. 8.1.2 North America Lisinopril Sales by Type (2021-2032)
  4. 8.1.3 North America Lisinopril Price by Type (2021-2032)
  5. 8.2 North America Lisinopril Market Size by Application
  6. 8.2.1 North America Lisinopril Revenue by Application (2021-2032)
  7. 8.2.2 North America Lisinopril Sales by Application (2021-2032)
  8. 8.2.3 North America Lisinopril Price by Application (2021-2032)
  9. 8.3 North America Lisinopril Market Size by Country
  10. 8.3.1 North America Lisinopril Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Lisinopril Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Lisinopril Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Lisinopril Market Size by Type
  2. 9.1.1 Europe Lisinopril Revenue by Type (2021-2032)
  3. 9.1.2 Europe Lisinopril Sales by Type (2021-2032)
  4. 9.1.3 Europe Lisinopril Price by Type (2021-2032)
  5. 9.2 Europe Lisinopril Market Size by Application
  6. 9.2.1 Europe Lisinopril Revenue by Application (2021-2032)
  7. 9.2.2 Europe Lisinopril Sales by Application (2021-2032)
  8. 9.2.3 Europe Lisinopril Price by Application (2021-2032)
  9. 9.3 Europe Lisinopril Market Size by Country
  10. 9.3.1 Europe Lisinopril Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Lisinopril Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Lisinopril Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Lisinopril Market Size by Type
  2. 10.1.1 China Lisinopril Revenue by Type (2021-2032)
  3. 10.1.2 China Lisinopril Sales by Type (2021-2032)
  4. 10.1.3 China Lisinopril Price by Type (2021-2032)
  5. 10.2 China Lisinopril Market Size by Application
  6. 10.2.1 China Lisinopril Revenue by Application (2021-2032)
  7. 10.2.2 China Lisinopril Sales by Application (2021-2032)
  8. 10.2.3 China Lisinopril Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lisinopril Market Size by Type
  2. 11.1.1 Asia Lisinopril Revenue by Type (2021-2032)
  3. 11.1.2 Asia Lisinopril Sales by Type (2021-2032)
  4. 11.1.3 Asia Lisinopril Price by Type (2021-2032)
  5. 11.2 Asia Lisinopril Market Size by Application
  6. 11.2.1 Asia Lisinopril Revenue by Application (2021-2032)
  7. 11.2.2 Asia Lisinopril Sales by Application (2021-2032)
  8. 11.2.3 Asia Lisinopril Price by Application (2021-2032)
  9. 11.3 Asia Lisinopril Market Size by Country
  10. 11.3.1 Asia Lisinopril Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Lisinopril Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Lisinopril Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lisinopril Market Size by Type
  2. 12.1.1 SAMEA Lisinopril Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Lisinopril Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Lisinopril Price by Type (2021-2032)
  5. 12.2 SAMEA Lisinopril Market Size by Application
  6. 12.2.1 SAMEA Lisinopril Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Lisinopril Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Lisinopril Price by Application (2021-2032)
  9. 12.3 SAMEA Lisinopril Market Size by Country
  10. 12.3.1 SAMEA Lisinopril Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Lisinopril Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Lisinopril Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Lisinopril Value Chain Analysis
  2. 13.1.1 Lisinopril Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Lisinopril Production Mode & Process
  6. 13.2 Lisinopril Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Lisinopril Distributors
  9. 13.2.3 Lisinopril Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst